Co-diagnostics, inc. appoints chief regulatory affairs officer

Salt lake city , aug. 29, 2023 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) ("co-dx™" or the "company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it is pleased to welcome ivory chang as the company's chief regulatory affairs officer. ms. chang's in-depth regulatory affairs experience has included time spent with several notable names in the diagnostics industry, including roche, boston scientific, bd biosciences, cepheid, thermo fisher scientific, and more.
CODX Ratings Summary
CODX Quant Ranking